Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma

11 Mar 2020

Abstract excerpt

Hepatocellular carcinoma (HCC) is closely associated with liver fibrosis. Hepatic stellate cells (HSC) and cancer-associated myofibroblasts are key players in liver fibrogenesis and hepatocarcinogenesis. Overexpression of fibroblast growth factor (FGF) receptors contributes to HCC development and progression. This study aimed to elucidate the role of FGFs in the HSC-HCC crosstalk. Analysis of the expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibroblast Growth Factor Research
Share to Liver physiology and pathology
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32161315
DOI: 10.1038/s41598-020-61510-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinomaPMID 32161315Read ↗

Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialinSemantic proximity Read ↗

Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than everSemantic proximity Read ↗

Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1Semantic proximity Read ↗

Targeting Hepatic Stellate Cells for the Prevention and Treatment of Liver Cirrhosis and Hepatocellular Carcinoma: Strategies and Clinical TranslationSemantic proximity Read ↗

Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cellsSemantic proximity Read ↗

Inhibition of DNMT3B expression in activated hepatic stellate cells overcomes chemoresistance in the tumor microenvironment of hepatocellular carcinomaSemantic proximity Read ↗

Role of fibroblast growth factor signalling in hepatic fibrosisSemantic proximity Read ↗

Dysregulation of miRNA Expression in Cancer Associated Fibroblasts (CAFs) and Its Consequences on the Tumor MicroenvironmentSemantic proximity Read ↗

Hepatocyte–Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular CarcinomaSemantic proximity Read ↗

The role of miR-29a in the regulation, function, and signaling of liver fibrosisSemantic proximity Read ↗

The Role of miR-29a in the Regulation, Function, and Signaling of Liver FibrosisSemantic proximity Read ↗

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.